You have 9 free searches left this month | for more free features.

Ophthalmic Solutions

Showing 2451 - 2475 of 2,869

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Contact Lens Solution Toxicity Trial in Azusa, Morrow, Louisville (RevitaLens, OptiFree PureMoist)

Unknown status
  • Contact Lens Solution Toxicity
  • RevitaLens
  • OptiFree PureMoist
  • Azusa, California
  • +2 more
May 25, 2013

Conjunctivitis, Allergic Trial in Philadelphia (alcaftadine 0.25% ophthalmic solution, olopatadine 0.2% ophthalmic solution,

Completed
  • Conjunctivitis, Allergic
  • alcaftadine 0.25% ophthalmic solution
  • +2 more
  • Philadelphia, Pennsylvania
    (unnamed)
Jan 18, 2013

Contact Lens Solutions Trial in New York City (Opti-Free® RepleniSH® MPDS, ReNu MultiPlus®)

Completed
  • Contact Lens Solutions
  • Opti-Free® RepleniSH® MPDS
  • ReNu MultiPlus®
  • New York City, New York
    MVA/IVR
Apr 22, 2013

Dry Eye Syndromes Trial in Vienna (0.05% Chitosan-N-Acetylcysteine eye drops, 0.1% Chitosan-N-Acetylcysteine eye drops)

Completed
  • Dry Eye Syndromes
  • 0.05% Chitosan-N-Acetylcysteine eye drops
  • 0.1% Chitosan-N-Acetylcysteine eye drops
  • Vienna, Austria
    Department of Clinical Pharmacology, Medical University of Vienn
Dec 7, 2012

Older Adults Trial in Taipei (comprehensive care)

Completed
  • Older Adults
  • comprehensive care
  • Taipei, Taiwan
    School of Nursing, National Taiwan University
Oct 24, 2013

Conjunctical Flora Trial (gatifloxacin, moxifloxacin)

Withdrawn
  • Conjunctical Flora
  • gatifloxacin, moxifloxacin
  • (no location specified)
Jun 12, 2013

Bacterial Conjunctivitis Trial in Rochester (Besivance, Vehicle)

Completed
  • Bacterial Conjunctivitis
  • Rochester, New York
    Bausch & Lomb, Inc.
Mar 19, 2013

Dry Eye Syndrome Trial in Vienna (Chitosan-N-acetylcysteine eye drops (concentration of 0.1%), Physiological saline solution)

Completed
  • Dry Eye Syndrome
  • Chitosan-N-acetylcysteine eye drops (concentration of 0.1%)
  • Physiological saline solution
  • Vienna, Austria
    Department of Clinical Pharmacology, Medical University of Vienn
Dec 10, 2012

Dry Eye Syndromes Trial in Japan (, 1% OPC-12759 ophthalmic suspension, 2% OPC-12759 ophthalmic suspension)

Completed
  • Dry Eye Syndromes
  • placebo
  • +2 more
  • Chubu region, Japan
  • +5 more
Jun 4, 2013

Open-angle Glaucoma, Ocular Hypertension Trial (Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN

Completed
  • Open-angle Glaucoma
  • Ocular Hypertension
  • Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)
  • Latanoprost ophthalmic solution 0.005% (XALATAN®)
  • (no location specified)
Jul 20, 2012

Chronic Low Back Pain Trial in Maastricht (Exposure therapy)

Unknown status
  • Chronic Low Back Pain
  • Exposure therapy
  • Maastricht, Netherlands
    Maastricht medical care center, department of rehabilitation
Oct 23, 2013

Hemangioma Trial in Bangkoknoi (0.5% timolol maleate eye drop, Normal saline)

Unknown status
  • Hemangioma
  • 0.5% timolol maleate eye drop
  • Normal saline
  • Bangkoknoi, Bangkok, Thailand
    Faculty of Medicine Siriraj Hospital Mahidol University
Nov 26, 2012

Spinal Surgery Trial in Seoul (0.9% normal saline, plasmalyte)

Completed
  • Spinal Surgery
  • 0.9% normal saline
  • plasmalyte
  • Seoul, Korea, Republic of
    Department of Anesthesiology and Pain Medicine, Yonsei Universit
May 13, 2013

Spinal Cord Injury Trial in Aylesbury (Tobii™ Eyegaze System)

Unknown status
  • Spinal Cord Injury
  • Tobii™ Eyegaze System
  • Aylesbury, Buckinghamshire, United Kingdom
    National Spinal Injuries Centre, Stoke Mandeville Hospital
Sep 12, 2013

Eye Infections, Postoperative Complications Trial in United States (Prednisolone and Tobramycin, Prednisolone)

Completed
  • Eye Infections
  • Postoperative Complications
  • Great Bend, Kansas
  • +5 more
Mar 13, 2013

Allergic Conjunctivitis Trial in Fort Worth (Olopatadine HCl, 0.1% ophthalmic solution (Patanol), Dextran 70 0.1%, hydroxypropyl

Completed
  • Allergic Conjunctivitis
  • Olopatadine hydrochloride, 0.1% ophthalmic solution (Patanol)
  • Dextran 70 0.1%, hydroxypropyl methylcellulose 0.3% (Tears Naturale II)
  • Fort Worth, Texas
    Contact Alcon Call Center for Trial Locations
Dec 16, 2012

Open-angle Glaucoma, Ocular Hypertension Trial in Austin, San Antonio (DE-112, DE-112 Vehicle Solution, Timolol Maleate

Completed
  • Open-angle Glaucoma
  • Ocular Hypertension
  • Austin, Texas
  • +1 more
Dec 14, 2012

Strabismus, Surgery, Endophthalmitis Trial in Germany, Netherlands (Preoperative conjunctival irrigation with 5% or 1.25% PI)

Completed
  • Strabismus
  • +2 more
  • Preoperative conjunctival irrigation with 5% or 1.25% PI
  • Greifswald, Germany
  • +8 more
Mar 4, 2013

Surgical Wound Infection Trial in Panama (Clorhexidine, Povidone)

Completed
  • Surgical Wound Infection
  • Clorhexidine
  • Povidone
  • Panama, Panama
    Saint Thomas Maternity Hospital
May 16, 2013

Dry Eye Disease Trial in New York (Systane Ultra, Saline solution, Maxidex)

Completed
  • Dry Eye Disease
  • Systane Ultra
  • +2 more
  • New York, New York
    Mount Sinai School of Medicine
Jan 22, 2013

Dry Eye Syndrome Trial (Systane Ultra Lubricant Eye Drops, Hialid 0.1 Artificial Tears Eye Drops, Unisol 4 Saline Solution)

Completed
  • Dry Eye Syndrome
  • Systane Ultra Lubricant Eye Drops
  • +2 more
  • (no location specified)
Oct 26, 2012

Dry Eye Syndromes Trial in Irvine (Ecabet, Placebo)

Completed
  • Dry Eye Syndromes
  • Irvine, California
    (unnamed)
Mar 13, 2013

Dry Eye Syndromes Trial in Lewiston, Andover, Dover (Ecabet 2.83%, Ecabet 3.70%, Vehicle)

Completed
  • Dry Eye Syndromes
  • Ecabet 2.83%
  • +2 more
  • Lewiston, Maine
  • +2 more
Mar 13, 2013

Healthy Volunteers Trial in Rouen (Glutamine, Glucose, glutamine-antioxidants containing solution)

Completed
  • Healthy Volunteers
  • Rouen, France
    University Hospital of Rouen
Jun 17, 2013

Allergic Conjunctivitis Trial in Kolkata (Olopatadine Hydrochloride Ophthalmic Solution, 0.2%)

Completed
  • Allergic Conjunctivitis
  • Olopatadine Hydrochloride Ophthalmic Solution, 0.2%
  • Kolkata, India
    (unnamed)
Sep 16, 2012